| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| AL(L) | 162 | 75.0% | -7.34 | 1 | 0.6% |
| LH(L) | 30 | 13.9% | 1.90 | 112 | 62.6% |
| SLP(L) | 15 | 6.9% | 1.93 | 57 | 31.8% |
| CentralBrain-unspecified | 4 | 1.9% | 0.32 | 5 | 2.8% |
| CA(L) | 3 | 1.4% | -0.58 | 2 | 1.1% |
| SCL(L) | 0 | 0.0% | inf | 2 | 1.1% |
| SMP(L) | 2 | 0.9% | -inf | 0 | 0.0% |
| PLP(L) | 0 | 0.0% | 0.00 | 0 | 0.0% |
| upstream partner | # | NT | conns M_lvPNm38 | % In | CV |
|---|---|---|---|---|---|
| ORN_VM6v | 8 | ACh | 24 | 19.0% | 0.7 |
| ORN_VL1 | 3 | ACh | 14 | 11.1% | 0.6 |
| ORN_VM6m | 6 | ACh | 8 | 6.3% | 0.4 |
| v2LN32 (L) | 1 | Glu | 6 | 4.8% | 0.0 |
| v2LN30 (L) | 1 | unc | 6 | 4.8% | 0.0 |
| DNp44 (L) | 1 | ACh | 4 | 3.2% | 0.0 |
| VM6_adPN (L) | 1 | ACh | 4 | 3.2% | 0.0 |
| CB3383 (L) | 1 | ACh | 3 | 2.4% | 0.0 |
| v2LNX01 (R) | 1 | unc | 3 | 2.4% | 0.0 |
| VA3_adPN (L) | 2 | ACh | 3 | 2.4% | 0.3 |
| lLN2X02 (L) | 1 | GABA | 2 | 1.6% | 0.0 |
| DM3_vPN (L) | 1 | GABA | 2 | 1.6% | 0.0 |
| CB1154 (L) | 1 | Glu | 2 | 1.6% | 0.0 |
| M_vPNml75 (L) | 1 | GABA | 2 | 1.6% | 0.0 |
| CB3202 (L) | 1 | ACh | 2 | 1.6% | 0.0 |
| VP2+Z_lvPN (L) | 1 | ACh | 2 | 1.6% | 0.0 |
| vLN24 (L) | 1 | ACh | 2 | 1.6% | 0.0 |
| lLN2X11 (L) | 1 | ACh | 2 | 1.6% | 0.0 |
| VM6_lvPN (L) | 2 | ACh | 2 | 1.6% | 0.0 |
| CB2208 (L) | 2 | ACh | 2 | 1.6% | 0.0 |
| M_vPNml53 (L) | 2 | GABA | 2 | 1.6% | 0.0 |
| lLN2R_a (L) | 2 | GABA | 2 | 1.6% | 0.0 |
| v2LNX01 (L) | 1 | unc | 1 | 0.8% | 0.0 |
| LHAV2b10 (L) | 1 | ACh | 1 | 0.8% | 0.0 |
| CB1752 (L) | 1 | ACh | 1 | 0.8% | 0.0 |
| CB3733 (L) | 1 | GABA | 1 | 0.8% | 0.0 |
| CB1846 (L) | 1 | Glu | 1 | 0.8% | 0.0 |
| M_vPNml69 (L) | 1 | GABA | 1 | 0.8% | 0.0 |
| CB3727 (L) | 1 | Glu | 1 | 0.8% | 0.0 |
| CB2992 (L) | 1 | Glu | 1 | 0.8% | 0.0 |
| CB1735 (L) | 1 | Glu | 1 | 0.8% | 0.0 |
| CB1246 (L) | 1 | GABA | 1 | 0.8% | 0.0 |
| M_lPNm11D (L) | 1 | ACh | 1 | 0.8% | 0.0 |
| VP2_l2PN (L) | 1 | ACh | 1 | 0.8% | 0.0 |
| M_vPNml73 (L) | 1 | GABA | 1 | 0.8% | 0.0 |
| LHPV4j2 (L) | 1 | Glu | 1 | 0.8% | 0.0 |
| CB0373 (L) | 1 | Glu | 1 | 0.8% | 0.0 |
| lLN2P_c (L) | 1 | GABA | 1 | 0.8% | 0.0 |
| v2LN3A (L) | 1 | unc | 1 | 0.8% | 0.0 |
| LHPV4j3 (L) | 1 | Glu | 1 | 0.8% | 0.0 |
| lLN2P_b (L) | 1 | GABA | 1 | 0.8% | 0.0 |
| DA3_adPN (L) | 1 | ACh | 1 | 0.8% | 0.0 |
| CB1608 (L) | 1 | Glu | 1 | 0.8% | 0.0 |
| DNp25 (L) | 1 | GABA | 1 | 0.8% | 0.0 |
| LHCENT13_b (L) | 1 | GABA | 1 | 0.8% | 0.0 |
| lLN2X12 (L) | 1 | ACh | 1 | 0.8% | 0.0 |
| VM4_adPN (L) | 1 | ACh | 1 | 0.8% | 0.0 |
| VP4+VL1_l2PN (L) | 1 | ACh | 1 | 0.8% | 0.0 |
| SAD071 (L) | 1 | GABA | 1 | 0.8% | 0.0 |
| downstream partner | # | NT | conns M_lvPNm38 | % Out | CV |
|---|---|---|---|---|---|
| LHPV4b4 (L) | 5 | Glu | 27 | 10.8% | 0.4 |
| M_vPNml53 (L) | 5 | GABA | 20 | 8.0% | 1.0 |
| LHAV3k6 (L) | 1 | ACh | 16 | 6.4% | 0.0 |
| LHPV4j3 (L) | 1 | Glu | 13 | 5.2% | 0.0 |
| CB0367 (L) | 1 | Glu | 12 | 4.8% | 0.0 |
| LHAV2b5 (L) | 1 | ACh | 8 | 3.2% | 0.0 |
| LHPV5i1 (L) | 1 | ACh | 8 | 3.2% | 0.0 |
| LHAV7a1_a (L) | 1 | Glu | 6 | 2.4% | 0.0 |
| CB3240 (L) | 1 | ACh | 6 | 2.4% | 0.0 |
| LHAV5b1 (L) | 2 | ACh | 6 | 2.4% | 0.3 |
| CB2600 (L) | 2 | Glu | 6 | 2.4% | 0.0 |
| LHPV4i3 (L) | 2 | Glu | 6 | 2.4% | 0.0 |
| CB4122 (L) | 1 | Glu | 5 | 2.0% | 0.0 |
| LHAV5e1 (L) | 1 | Glu | 5 | 2.0% | 0.0 |
| M_vPNml73 (L) | 1 | GABA | 5 | 2.0% | 0.0 |
| LHAD3a8 (L) | 1 | ACh | 4 | 1.6% | 0.0 |
| CB1057 (L) | 1 | Glu | 4 | 1.6% | 0.0 |
| FB1E_b (L) | 1 | Glu | 4 | 1.6% | 0.0 |
| CB0373 (L) | 1 | Glu | 4 | 1.6% | 0.0 |
| CSD (L) | 1 | 5-HT | 4 | 1.6% | 0.0 |
| CB1608 (L) | 2 | Glu | 4 | 1.6% | 0.5 |
| SLP164 (L) | 1 | ACh | 3 | 1.2% | 0.0 |
| CB1846 (L) | 1 | Glu | 3 | 1.2% | 0.0 |
| CB1570 (L) | 1 | ACh | 3 | 1.2% | 0.0 |
| CB2148 (L) | 2 | ACh | 3 | 1.2% | 0.3 |
| LHAV5b2 (L) | 2 | ACh | 3 | 1.2% | 0.3 |
| CB4131 (L) | 1 | Glu | 2 | 0.8% | 0.0 |
| LHAD3b1_a (L) | 1 | ACh | 2 | 0.8% | 0.0 |
| CB1160 (L) | 1 | Glu | 2 | 0.8% | 0.0 |
| M_vPNml68 (L) | 1 | GABA | 2 | 0.8% | 0.0 |
| M_vPNml88 (L) | 1 | GABA | 2 | 0.8% | 0.0 |
| SLP363 (L) | 1 | Glu | 2 | 0.8% | 0.0 |
| LHPV2b5 (L) | 1 | GABA | 2 | 0.8% | 0.0 |
| FB1D (L) | 1 | Glu | 2 | 0.8% | 0.0 |
| LHAV2m1 (L) | 1 | GABA | 2 | 0.8% | 0.0 |
| LHPV8a1 (L) | 1 | ACh | 2 | 0.8% | 0.0 |
| aMe13 (R) | 1 | ACh | 2 | 0.8% | 0.0 |
| CSD (R) | 1 | 5-HT | 2 | 0.8% | 0.0 |
| CB2208 (L) | 2 | ACh | 2 | 0.8% | 0.0 |
| LHPV4c2 (L) | 2 | Glu | 2 | 0.8% | 0.0 |
| LHPV6f3_b (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| M_vPNml86 (L) | 1 | GABA | 1 | 0.4% | 0.0 |
| SLP266 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| LHAV5a9_a (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| CB1326 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| VL1_vPN (L) | 1 | GABA | 1 | 0.4% | 0.0 |
| CB4107 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| SLP322 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| CB1617 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| LHPV5b6 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| CB3383 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| LHPV6h3,SLP276 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| CB3318 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| CB1909 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| CB2992 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| SMP305 (L) | 1 | unc | 1 | 0.4% | 0.0 |
| CB3055 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| CB3173 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| LHAV4d1 (L) | 1 | unc | 1 | 0.4% | 0.0 |
| LHPV6f5 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| CB1352 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| CB1626 (L) | 1 | unc | 1 | 0.4% | 0.0 |
| CL087 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| LHPV2b4 (L) | 1 | GABA | 1 | 0.4% | 0.0 |
| SLP465 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| LHAV2b9 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| SLP360_d (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| CB4119 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| CB1685 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| SLP249 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| CB1212 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| M_lvPNm37 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| SLP457 (L) | 1 | unc | 1 | 0.4% | 0.0 |
